NASDAQ:CNMD - CONMED Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $67.38 +1.59 (+2.42 %) (As of 01/16/2019 04:00 PM ET)Previous Close$65.79Today's Range$65.80 - $67.4452-Week Range$55.23 - $83.49Volume247,311 shsAverage Volume194,074 shsMarket Capitalization$1.82 billionP/E Ratio35.65Dividend Yield1.24%Beta0.63 ProfileDiscussionAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, plastic, ENT, neurological, spinal, and cardiothoracic surgeries; sports biologics and tissue products; and surgical visualization products. It offers orthopedic surgery products under Hall, CONMED Linvatec, Concept, and Shutt brands. The company also offers general surgery product in the areas of advanced surgical comprising clinical insufflation system; electrosurgical products; endomechanical products comprising instruments, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors; and uterine manipulator (VCARE) for use in increasing the efficiency of laparoscopic hysterectomies and other gynecologic laparoscopic procedures. In addition, it offers general surgery product in the areas of endoscopic technologies, including minimally invasive diagnostic and therapeutic products; critical care products cover a line of vital signs, cardiac monitoring, and patient care products, including ECG electrodes and accessories, cardiac defibrillation and pacing pads, and suction instruments and tubing; and physician's office electrosurgical product used by dermatologists. The company's products are used by surgeons and physicians in orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology. CONMED Corporation was founded in 1970 and is headquartered in Utica, New York. Receive CNMD News and Ratings via Email Sign-up to receive the latest news and ratings for CNMD and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Electromedical equipment Sub-IndustryHealth Care Equipment SectorMedical Current SymbolNASDAQ:CNMD Previous Symbol CUSIP20741010 Webwww.conmed.com Phone315-797-8375Debt Debt-to-Equity Ratio0.68 Current Ratio2.20 Quick Ratio1.27Price-To-Earnings Trailing P/E Ratio35.65 Forward P/E Ratio31.05 P/E Growth2.33 Sales & Book Value Annual Sales$796.39 million Price / Sales2.38 Cash Flow$4.1696 per share Price / Cash Flow16.16 Book Value$22.60 per share Price / Book2.98Profitability EPS (Most Recent Fiscal Year)$1.89 Net Income$55.48 million Net Margins8.56% Return on Equity9.51% Return on Assets4.51%Miscellaneous Employees3,100 Outstanding Shares28,130,000Market Cap$1.82 billion OptionableOptionable CONMED (NASDAQ:CNMD) Frequently Asked Questions What is CONMED's stock symbol? CONMED trades on the NASDAQ under the ticker symbol "CNMD." How often does CONMED pay dividends? What is the dividend yield for CONMED? CONMED declared a quarterly dividend on Friday, November 9th. Stockholders of record on Friday, December 14th will be given a dividend of $0.20 per share on Monday, January 7th. This represents a $0.80 annualized dividend and a dividend yield of 1.19%. The ex-dividend date of this dividend is Thursday, December 13th. View CONMED's Dividend History. How were CONMED's earnings last quarter? CONMED Co. (NASDAQ:CNMD) released its earnings results on Thursday, November, 1st. The medical technology company reported $0.46 earnings per share for the quarter, topping analysts' consensus estimates of $0.45 by $0.01. The medical technology company had revenue of $202.30 million for the quarter, compared to analysts' expectations of $198.51 million. CONMED had a net margin of 8.56% and a return on equity of 9.51%. The firm's quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.42 EPS. View CONMED's Earnings History. When is CONMED's next earnings date? CONMED is scheduled to release their next quarterly earnings announcement on Tuesday, January 22nd 2019. View Earnings Estimates for CONMED. What guidance has CONMED issued on next quarter's earnings? CONMED issued an update on its FY18 earnings guidance on Thursday, November, 1st. The company provided earnings per share guidance of $2.15-2.20 for the period, compared to the Thomson Reuters consensus estimate of $2.17. CONMED also updated its FY 2018 guidance to $2.15-2.20 EPS. What price target have analysts set for CNMD? 3 equities research analysts have issued twelve-month price targets for CONMED's shares. Their predictions range from $78.00 to $83.00. On average, they anticipate CONMED's stock price to reach $80.6667 in the next year. This suggests a possible upside of 19.7% from the stock's current price. View Analyst Price Targets for CONMED. What is the consensus analysts' recommendation for CONMED? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CONMED in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for CONMED. Has CONMED been receiving favorable news coverage? Headlines about CNMD stock have been trending somewhat negative recently, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. CONMED earned a daily sentiment score of -1.2 on InfoTrie's scale. They also gave media coverage about the medical technology company a news buzz of 5.0 out of 10, meaning that recent news coverage is somewhat likely to have an effect on the company's share price in the next few days. Who are some of CONMED's key competitors? Some companies that are related to CONMED include Masimo (MASI), LivaNova (LIVN), GETINGE AB/ADR (GNGBY), NxStage Medical (NXTM), Natus Medical (BABY), Viewray (VRAY), AxoGen (AXGN), Semler Scientific (SMLR), BioLife Solutions (BLFS), Cutera (CUTR), Rockwell Medical (RMTI), Electrocore (ECOR), Fonar (FONR), Zynex (ZYXI) and Stereotaxis (STXS). Who are CONMED's key executives? CONMED's management team includes the folowing people: Mr. Curt R. Hartman, CEO, Pres & Director (Age 55)Mr. Patrick J. Beyer, Pres of CONMED International (Age 53)Mr. Stanley W. Peters III, VP & GM of U.S. Advanced Surgical (Age 44)Mr. Nathan Folkert, VP & GM of U.S. Orthopedics (Age 44)Mr. Todd W. Garner, Exec. VP & CFO (Age 50) Who are CONMED's major shareholders? CONMED's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Louisiana State Employees Retirement System (0.03%). Company insiders that own CONMED stock include Charles Farkas, Curt R Hartman, Daniel Jonas, Dirk Kuyper, Heather L Cohen, Jo Ann Golden, Luke A Pomilio, Mark E Tryniski, Nathan Folkert, Peter K Shagory, Stanley W Peters III and Terence M Berge. View Institutional Ownership Trends for CONMED. Which institutional investors are selling CONMED stock? CNMD stock was sold by a variety of institutional investors in the last quarter, including Louisiana State Employees Retirement System. Company insiders that have sold CONMED company stock in the last year include Daniel Jonas, Jo Ann Golden, Luke A Pomilio, Nathan Folkert, Peter K Shagory, Stanley W Peters III and Terence M Berge. View Insider Buying and Selling for CONMED. How do I buy shares of CONMED? Shares of CNMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is CONMED's stock price today? One share of CNMD stock can currently be purchased for approximately $67.38. How big of a company is CONMED? CONMED has a market capitalization of $1.82 billion and generates $796.39 million in revenue each year. The medical technology company earns $55.48 million in net income (profit) each year or $1.89 on an earnings per share basis. CONMED employs 3,100 workers across the globe. What is CONMED's official website? The official website for CONMED is http://www.conmed.com. How can I contact CONMED? CONMED's mailing address is 525 FRENCH ROAD, UTICA NY, 13502. The medical technology company can be reached via phone at 315-797-8375. MarketBeat Community Rating for CONMED (NASDAQ CNMD)Community Ranking: 2.8 out of 5 ( )Outperform Votes: 309 (Vote Outperform)Underperform Votes: 241 (Vote Underperform)Total Votes: 550MarketBeat's community ratings are surveys of what our community members think about CONMED and other stocks. Vote "Outperform" if you believe CNMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CNMD will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/16/2019 by MarketBeat.com StaffFeatured Article: How Does the Quiet Period Work?